Caplin Point Laboratories Ltd (CAPLIPOINT) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 640544,
    "name": "Caplin Point Lab",
    "stock_name": "Caplin Point Lab",
    "full_name": "Caplin Point Laboratories Ltd",
    "name_url": "stocks-analysis/caplin-point-lab",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "2,346.80",
    "chg": 13.55,
    "chgp": "0.58%",
    "dir": 1,
    "prev_price": "2,333.25",
    "mcapval": "18,085.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 524742,
    "symbol": "CAPLIPOINT",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE475E01026",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "58.55 k",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/caplin-point-lab-640544-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Caplin Point Laboratories Ltd Shows Technical Momentum Shift Amid Mixed Indicators",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/caplin-point-laboratories-ltd-shows-technical-momentum-shift-amid-mixed-indicators-4000144",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/CaplinPointLabo_technicaldot_4000144.png",
        "date": "2026-05-20 08:02:52",
        "description": "Caplin Point Laboratories Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has exhibited a notable shift in its technical momentum, moving from a mildly bearish to a mildly bullish trend. This change is underscored by a complex interplay of technical indicators including MACD, RSI, Bollinger Bands, and moving averages, signalling a nuanced outlook for investors as the stock trades near ₹2,038."
      },
      {
        "title": "Caplin Point Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/caplin-point-laboratories-ltd-is-rated-sell-3985307",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/CaplinPointLabo_mojoScore_3985307.png",
        "date": "2026-05-11 10:11:13",
        "description": "Caplin Point Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 May 2026, providing investors with an up-to-date perspective on its performance and outlook."
      },
      {
        "title": "When is the next results date for Caplin Point Laboratories Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-caplin-point-laboratories-ltd-3982464",
        "imagepath": "",
        "date": "2026-05-08 23:17:00",
        "description": "The next results date for Caplin Point Laboratories Ltd is scheduled for 14 May 2026...."
      },
      {
        "title": "Caplin Point Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/caplin-point-laboratories-ltd-is-rated-sell-3969923",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/CaplinPointLabo_mojoScore_3969923.png",
        "date": "2026-04-30 10:11:00",
        "description": "Caplin Point Laboratories Ltd is rated 'Sell' by MarketsMOJO. This rating was last updated on 25 Nov 2025, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed below are current as of 30 April 2026, providing investors with an up-to-date view of the company’s position in the market."
      },
      {
        "title": "Caplin Point Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/caplin-point-laboratories-ltd-is-rated-sell-3952876",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/CaplinPointLabo_mojoScore_3952876.png",
        "date": "2026-04-19 10:10:37",
        "description": "Caplin Point Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 April 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "Caplin Point Laboratories Ltd Faces Bearish Momentum Amid Technical Downturn",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/caplin-point-laboratories-ltd-faces-bearish-momentum-amid-technical-downturn-3946616",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/CaplinPointLabo_technicaldot_3946616.png",
        "date": "2026-04-15 08:02:57",
        "description": "Caplin Point Laboratories Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has recently experienced a notable shift in its technical momentum, signalling a bearish trend. Despite a strong long-term performance relative to the Sensex, recent technical indicators suggest caution for investors as the stock’s momentum deteriorates amid weakening moving averages and mixed signals from key oscillators."
      },
      {
        "title": "Caplin Point Laboratories Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/caplin-point-laboratories-ltd-technical-momentum-shifts-amid-mixed-market-signals-3943968",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/CaplinPointLabo_technicaldot_3943968.png",
        "date": "2026-04-13 08:02:26",
        "description": "Caplin Point Laboratories Ltd has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bearish and mildly bearish signals across key indicators. Despite a 2.55% rise in the latest session to ₹1,705.10, the stock’s technical parameters suggest cautious investor sentiment amid a broader small-cap pharmaceutical sector backdrop."
      },
      {
        "title": "Caplin Point Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/caplin-point-laboratories-ltd-is-rated-sell-3937332",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/CaplinPointLabo_mojoScore_3937332.png",
        "date": "2026-04-08 10:10:35",
        "description": "Caplin Point Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 Nov 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 08 April 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Caplin Point Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/caplin-point-laboratories-ltd-is-rated-sell-3921430",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/CaplinPointLabo_mojoScore_3921430.png",
        "date": "2026-03-28 10:10:27",
        "description": "Caplin Point Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 March 2026, providing investors with the latest insights into the company’s performance and outlook."
      }
    ],
    "total": 15,
    "sid": "640544",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/caplin-point-laboratories-640544"
  },
  "announcements": [
    {
      "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
      "datetime": "29-May-2026",
      "details": "Annual Secretarial Compliance report for the year ended March 31 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "22-May-2026",
      "details": "Intimation of Schedule of Analyst / Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "21-May-2026",
      "details": "Transcript for Earnings call- Q4- FY 2025-26",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Caplin Point Laboratories Ltd has declared <strong>200%</strong> dividend, ex-date: 29 May 26",
          "dt": "2026-05-29",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Caplin Point Laboratories Ltd has announced <strong>2:10</strong> stock split, ex-date: 19 Oct 16",
          "dt": "2016-10-19",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Caplin Point Laboratories Ltd Shows Technical Momentum Shift Amid Mixed Indicators

2026-05-20 08:02:52

Caplin Point Laboratories Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has exhibited a notable shift in its technical momentum, moving from a mildly bearish to a mildly bullish trend. This change is underscored by a complex interplay of technical indicators including MACD, RSI, Bollinger Bands, and moving averages, signalling a nuanced outlook for investors as the stock trades near ₹2,038.

Caplin Point Laboratories Ltd is Rated Sell

2026-05-11 10:11:13

Caplin Point Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 May 2026, providing investors with an up-to-date perspective on its performance and outlook.

When is the next results date for Caplin Point Laboratories Ltd?

2026-05-08 23:17:00

The next results date for Caplin Point Laboratories Ltd is scheduled for 14 May 2026....

Caplin Point Laboratories Ltd is Rated Sell

2026-04-30 10:11:00

Caplin Point Laboratories Ltd is rated 'Sell' by MarketsMOJO. This rating was last updated on 25 Nov 2025, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed below are current as of 30 April 2026, providing investors with an up-to-date view of the company’s position in the market.

Caplin Point Laboratories Ltd is Rated Sell

2026-04-19 10:10:37

Caplin Point Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 April 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trend, and technical outlook.

Caplin Point Laboratories Ltd Faces Bearish Momentum Amid Technical Downturn

2026-04-15 08:02:57

Caplin Point Laboratories Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has recently experienced a notable shift in its technical momentum, signalling a bearish trend. Despite a strong long-term performance relative to the Sensex, recent technical indicators suggest caution for investors as the stock’s momentum deteriorates amid weakening moving averages and mixed signals from key oscillators.

Caplin Point Laboratories Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-04-13 08:02:26

Caplin Point Laboratories Ltd has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bearish and mildly bearish signals across key indicators. Despite a 2.55% rise in the latest session to ₹1,705.10, the stock’s technical parameters suggest cautious investor sentiment amid a broader small-cap pharmaceutical sector backdrop.

Caplin Point Laboratories Ltd is Rated Sell

2026-04-08 10:10:35

Caplin Point Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 Nov 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 08 April 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook.

Caplin Point Laboratories Ltd is Rated Sell

2026-03-28 10:10:27

Caplin Point Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 March 2026, providing investors with the latest insights into the company’s performance and outlook.

View All News